Semaglutide in Las Vegas
You can get semaglutide in Las Vegas through a physician evaluation at LiveNow Longevity — a board-certified MD prescribes it after labs, and the medication is dispensed by a licensed US pharmacy at pass-through cost with no markup. The $88 evaluation is the first step.
Medically reviewed by Charles Kamen, MD, board-certified neurologist ·
Semaglutide is a GLP-1 receptor agonist, FDA-approved as Wegovy® for chronic weight management and as Ozempic® for type 2 diabetes (both verifiable in the FDA drug database). It works, and it works best and most safely inside an actual medical program: baseline labs, individualized titration, a nutrition and muscle-preservation strategy, and a physician who follows your progress.
Las Vegas is full of places that will sell you semaglutide. LiveNow Longevity is a physician practice, not a med spa: Dr. Charles Kamen, MD evaluates you first, prescribes only when appropriate, and your medication comes from a licensed US pharmacy at pass-through cost with no markup. If semaglutide is not right for you, you will hear that too, at the $88 evaluation rather than after months of auto-billing.
In person at Eastern Avenue and the 215 in southeast Las Vegas, or by secure telehealth anywhere in Nevada. For the full picture across every GLP-1-pathway option, see our GLP-1 medication comparison and semaglutide vs. tirzepatide vs. retatrutide guide.
How Semaglutide Therapy Works Here
$88 evaluation with board-certified neurologist Dr. Charles Kamen, MD — applied toward your plan
Baseline labs before any prescription (metabolic panel, A1C, thyroid, and more as indicated)
Individualized dosing and slow titration to minimize side effects
Medication dispensed by licensed US pharmacies at pass-through cost, no markup
Protein targets and muscle-preservation strategy built into your plan
Scheduled physician follow-ups and an exit plan — not an auto-renewing subscription
How to get semaglutide in Las Vegas: 3 steps
Semaglutide is prescription-only in Nevada, so it always starts with a physician. At LiveNow Longevity the path is the same for everyone, and the pricing is transparent:
| Step | What happens | Cost |
|---|---|---|
| 1. Medical evaluation | Board-certified MD reviews your history, goals, and orders baseline labs (metabolic panel, A1C, thyroid as indicated). | $88, applied toward your plan |
| 2. Prescription, if appropriate | If semaglutide is clinically appropriate, Dr. Kamen prescribes it and it is dispensed by a licensed US pharmacy. | Pharmacy pass-through cost, no markup |
| 3. Monitored follow-up | Scheduled physician follow-ups manage tolerability and progress — in person at Eastern Ave and the 215, or by telehealth for Nevada residents. | Included in your plan |
Be cautious of “research chemical” or gray-market vendors advertising semaglutide online without a prescription — these products are not manufactured, tested, or labeled for human use, and we strongly recommend against them.
What the Trials Showed
Semaglutide’s evidence base includes two landmark NEJM trials: STEP 1, the pivotal weight-management trial, and SELECT, a cardiovascular-outcomes trial in people with overweight or obesity and existing heart disease. These are trial averages from large randomized studies, not individual guarantees. Results vary widely.
| Trial | Result | Context |
|---|---|---|
| STEP 1 (obesity, no diabetes) | ~14.9% average weight loss at 68 weeks | Randomized, placebo-controlled, 1,961 participants |
| STEP 1 — share losing ≥15% of body weight | ~50.5% of participants | vs. ~4.9% on placebo |
| SELECT (cardiovascular outcomes) | 20% relative reduction in major cardiovascular events | 17,604 participants with existing cardiovascular disease and overweight/obesity, no diabetes |
For comparison, the SURMOUNT-1 trial of tirzepatide (a dual GLP-1/GIP agonist) reported an average of about 20.9% weight loss at 72 weeks at the highest studied dose. Individual results vary widely and are not guaranteed. Semaglutide is a prescription medication used alongside nutrition and activity changes, not a substitute for them. See our tirzepatide in Las Vegas guide for that trial in full context.
Is Semaglutide FDA-Approved?
Yes. Semaglutide is FDA-approved as Wegovy® for chronic weight management and as Ozempic® for type 2 diabetes — both verifiable in the FDA drug database. Compounded versions of semaglutide also exist, produced by licensed 503A/503B compounding pharmacies under a physician’s prescription when clinically indicated — these are not FDA-approved finished products, and are a different category from brand-name Ozempic or Wegovy. We use FDA-approved semaglutide when appropriate for your plan.
One medication that is not available anywhere, including Las Vegas, is retatrutide, a newer, investigational triple-receptor agonist still in Phase 3 trials. It cannot be dispensed as a standard prescription while it remains unapproved. See our retatrutide in Las Vegas guide for the current research and FDA-approval outlook.
Semaglutide vs. Tirzepatide vs. Retatrutide
| Medication | Receptor targets | FDA status | Available now? |
|---|---|---|---|
| Semaglutide | GLP-1 | FDA-approved | Yes — after evaluation |
| Tirzepatide | GLP-1 + GIP | FDA-approved | Yes — after evaluation |
| Retatrutide | GLP-1 + GIP + glucagon | Investigational (not approved) | No — ask Dr. Kamen |
Semaglutide in Las Vegas — FAQ
How do I get semaglutide in Las Vegas?
Semaglutide is a prescription medication. At LiveNow Longevity, you start with an $88 medical evaluation with board-certified neurologist Dr. Charles Kamen, MD covering history, labs, and goals. If semaglutide is clinically appropriate, it is prescribed and dispensed through a licensed US pharmacy.
How much does semaglutide cost in Las Vegas?
At LiveNow Longevity, you start with an $88 physician evaluation that is applied toward your plan if you continue. Medication is then billed at pass-through cost with no markup; your exact monthly cost depends on dose and pharmacy, and is reviewed with you in person before you commit to anything.
Is semaglutide FDA-approved?
Yes. Semaglutide is FDA-approved as Wegovy® for chronic weight management and as Ozempic® for type 2 diabetes, both verifiable in the FDA drug database. Whether it is appropriate for you is a medical decision made after evaluation and labs.
Semaglutide or tirzepatide: which is better?
The right choice depends on your history, labs, tolerability, and goals. Semaglutide activates the GLP-1 receptor while tirzepatide activates both GLP-1 and GIP. The evaluation determines which one, if either, fits you. See our physician-reviewed comparison for the evidence.
What are common semaglutide side effects?
The most common semaglutide side effects are nausea, constipation, fatigue, and GI discomfort, especially during dose increases. Physician-managed titration, a nutrition strategy, and scheduled follow-ups exist precisely to manage this, and to catch the situations where the medication should be stopped.
Do you offer semaglutide by telehealth in Nevada?
Yes. Nevada residents can complete the evaluation and follow-ups by secure telehealth, with labs drawn near you. In-person care is available at our southeast Las Vegas clinic at Eastern Ave and the 215.
Does semaglutide help with more than weight loss?
Semaglutide is also studied for cardiovascular risk reduction. The SELECT trial found that in adults with overweight or obesity and existing cardiovascular disease, semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, and cardiovascular death) compared with placebo. This is a separate benefit from weight loss, and one more reason the medication decision belongs with a physician who reviews your full cardiovascular history, not a generic online form.
Who should not take semaglutide?
Semaglutide is generally not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2, and it requires caution in people with a history of pancreatitis or significant GI conditions. This is determined at your evaluation, based on your history and labs, not guessed at from a questionnaire.
Is compounded semaglutide the same as Ozempic or Wegovy?
No. FDA-approved Ozempic and Wegovy are manufactured by Novo Nordisk, while compounded semaglutide is produced by licensed 503A/503B compounding pharmacies under a physician prescription and is not an FDA-approved finished product. We use FDA-approved semaglutide when appropriate. See our full physician-reviewed breakdown of compounded vs brand semaglutide.
How do I know if I qualify for semaglutide?
Eligibility is determined at your evaluation. Dr. Kamen reviews your BMI, medical history, current medications, and baseline labs to decide whether semaglutide is an appropriate and safe option for you, or whether another approach fits better. There is no way to know for certain without that visit.
Should I choose semaglutide over retatrutide?
Retatrutide is not an option right now. It remains investigational and is not FDA-approved, so no clinic can prescribe it. Semaglutide is FDA-approved and available today after an evaluation. If you are curious where retatrutide stands, Dr. Kamen can walk you through the current research at your visit; see our retatrutide in Las Vegas guide for the full picture.
Selected Research
- Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002. (STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity).
- Lincoff AM, et al. N Engl J Med. 2023;389(24):2221-2232. (SELECT: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes).
- Jastreboff AM, et al. N Engl J Med. 2022;387(3):205-216. (SURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity).
- Frías JP, et al. N Engl J Med. 2021;385(6):503-515. (SURPASS-2: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes).
Trial-result sources only. Not a treatment claim or a guarantee. Individual results vary, and appropriateness is determined by a licensed physician after evaluation.
Physician-Led in Las Vegas
Find out if semaglutide is right for you
Schedule the $88 evaluation. After your labs and review, Dr. Kamen discusses an individualized plan and its costs, including whether tirzepatide fits you better. See the physician-reviewed comparison.
Ready to start your longevity care?
Book your $88 evaluation with Dr. Kamen today, online, by phone, or by text.
Prefer to talk? Call (702) 808-2650 or text us to book.
Also serving Henderson — or explore semaglutide weight loss in Las Vegas.